FDA Not In Favor Of Summit Therapeutics’ Endpoint Change To Pivotal Infection Trials
Summit Therapeutics Inc (NASDAQ: SMMT) announced that the FDA disagrees with its proposed change to the primary endpoint in Phase 3 Ri-CoDIFy studies.
Summit Therapeutics Q2 EPS $(0.27) Down From $(0.23) YoY, Sales $57.00K Down From $170.00K YoY
Summit Therapeutics (NASDAQ:SMMT) reported quarterly losses of $(0.27) per share. This is a 17.39 percent decrease over losses of $(0.23) per share from the same period last year. The company reported $57.00 thousand in
Summit Therapeutics Highlights Presentation Of Data From Phase II Studies At 31st European Congress of Clinical Microbiology & Infectious Diseases
Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit" or the "Company") is today displaying three preeminent ePosters at the prestigious 31st European Congress of Clinical Microbiology & Infectious
Summit Therapeutics Highlights Presentation Of Research Updates At Annual European Congress of Clinical Microbiology & Infectious Diseases Conference Jul. 9-12
Summit Therapeutics Inc. (NASDAQ:SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research updates at the 31st European Congress of Clinical Microbiology
50 Biggest Movers From Yesterday
Gainers
MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday.
Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22.
58 Biggest Movers From Yesterday
Gainers
BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results.
58 Biggest Movers From Yesterday
Gainers
Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday.
Last Week’s Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs.
A couple of chief executive officers and an executive board chair were among the insiders buying shares this past week.